Page 1 of Clinical Trials for Drug Epoetin Alfa, 517 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Last Updated: January 7, 2012
Condition(s): Anemia; Cervical Cancer; Drug/Agent Toxicity by Tissue/Organ; Radiation Toxicity
2
Completed
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
Last Updated: May 17, 2011
Condition(s): Anemia; Acquired Immunodeficiency Syndrome
3
Completed
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
Last Updated: May 17, 2011
Condition(s): Anemia; Acquired Immunodeficiency Syndrome
4
Completed
Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.
Last Updated: November 15, 2010
Condition(s): Chronic Kidney Disease
5
Completed
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug
Last Updated: May 17, 2011
Condition(s): Anemia; Neoplasms
6
Completed
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
Last Updated: September 14, 2011
Condition(s): Myocardial Infarction
7
Recruiting
The Clinical Evaluation of the Dose of Erythropoietins Trial
Last Updated: November 7, 2011
Condition(s): Kidney Failure, Chronic
8
Completed
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Last Updated: February 19, 2012
Condition(s): Anemia; Breast Cancer; Chronic Myeloproliferative Disorders; Drug/Agent Toxicity by Tissue/Organ; Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
9
Completed
Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects
Last Updated: August 23, 2006
Condition(s): Healthy Subjects
10
Completed
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Last Updated: February 29, 2012
Condition(s): Anemia
11
Completed
PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
Last Updated: May 18, 2011
Condition(s): Anemia; Renal Diseases
12
Terminated
The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Reducing the Number of Blood Transfusions Required by Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery
Last Updated: March 8, 2012
Condition(s): Hemostasis, Surgical
13
Completed
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
Last Updated: May 18, 2011
Condition(s): Kidney Diseases; Anemia
14
Completed
Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.
Last Updated: May 19, 2011
Condition(s): Anemia; Kidney Diseases
15
Not yet recruiting
Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery
Last Updated: August 25, 2011
Condition(s): Kidney Failure; Renal Failure
16
Completed
Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules
Last Updated: August 3, 2009
Condition(s): Bio-Equivalency of 2 Treatment Schedules in HD Patients
17
Completed
A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.
Last Updated: May 17, 2011
Condition(s): Anemia
18
Enrolling by invitation
Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
Last Updated: May 9, 2011
Condition(s): Chronic Kidney Disease Stages 3-5
19
Terminated
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Last Updated: November 17, 2010
Condition(s): Peripheral Neuropathy, Chemotherapy-induced
20
Recruiting
An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
Last Updated: March 12, 2012
Condition(s): Myelodysplastic Syndromes

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Epoetin+Alfa

Page 1 of Clinical Trials for Drug Epoetin Alfa, 517 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About